EP Patent

EP0543020B1 — Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide

Assigned to Meito Sangyo KK · Expires 1997-12-29 · 28y expired

What this patent protects

An oxidized composite comprising a water-soluble carboxypolysaccharide and ultrafine magnetic iron oxide particles. It has an extremely reduces toxicity and an excellent stability, exhibits scarcely any or no hypotensive activity even if directly administered into the blood vesse…

USPTO Abstract

An oxidized composite comprising a water-soluble carboxypolysaccharide and ultrafine magnetic iron oxide particles. It has an extremely reduces toxicity and an excellent stability, exhibits scarcely any or no hypotensive activity even if directly administered into the blood vessel of an animal, is reduced in the activity of platelet agglutination, and is useful in the medical field as, for example, a contrast medium for MRI and a pyrogenic agent for thermotherapy.

Drugs covered by this patent

Patent Metadata

Patent number
EP0543020B1
Jurisdiction
EP
Classification
—
Expires
1997-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Meito Sangyo KK
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.